RIQAS TDM EQA Programme by Randox Laboratories Ltd.
Manufacturer Randox Laboratories Ltd.
RIQAS is the largest global External Quality Assessment (EQA) scheme, used by more than 35,000 participants in 123 countries.The RIQAS Therapeutic Drug EQA programme is designed to monitor the performance of an impressive 18 therapeutic drugs.Features:Weighed in values are reported for each parameterAccredited to ISO/IEC 17043. Lyophilised for enhanced stability100% human serumBi-weekly reportingSubmit results and view reports online via RIQAS.NetRegister up to five instruments at no extra costW... Read more
The supplier does not provide quotations for this product through SelectScience. Browse these related products instead
RIQAS TDM EQA Programme
RIQAS is the largest global External Quality Assessment (EQA) scheme, used by more than 35,000 participants in 123 countries.
The RIQAS Therapeutic Drug EQA programme is designed to monitor the performance of an impressive 18 therapeutic drugs.
Features:
- Weighed in values are reported for each parameter
- Accredited to ISO/IEC 17043. Lyophilised for enhanced stability
- 100% human serum
- Bi-weekly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments at no extra cost
- Weighed in values reported for each parameter
Parameters:
- Amikacin
- Caffeine
- Carbamazepine
- Cyclosporine
- Digoxin
- Ethosuximide
- Gentamicin
- Lithium
- Methotrexate
- Paracetamol
- Phenobarbital
- Phenytoin
- Primidone
- Salicylic Acid
- Theophylline
- Tobramycin
- Valproic Acid
- Vancomycin
Product Overview
